Barclays »

Mersana Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $352k 152k 2.32
2023-09-30 $43k 34k 1.26
2023-06-30 $614k 187k 3.29
2023-03-31 $815k 198k 4.11
2022-12-31 $1.4M 232k 5.86
2022-09-30 $918k 136k 6.76
2022-06-30 $157k 34k 4.61
2022-03-31 $166k 42k 3.99
2021-12-31 $561k 90k 6.23
2021-09-30 $312k 33k 9.44
2021-06-30 $778k 57k 13.57
2021-03-31 $2.0M 125k 16.19
2020-12-31 $549k 21k 26.60
2020-09-30 $538k 29k 18.61
2020-06-30 $659k 28k 23.41
2020-03-31 $152k 26k 5.84
2019-12-31 $248k 43k 5.74
2019-09-30 $46k 29k 1.57
2019-06-30 $115k 28k 4.06
2019-03-31 $71k 14k 5.27
2018-12-31 $18k 4.4k 4.10
2018-09-30 $92k 9.2k 10.03
2018-06-30 $46k 2.6k 17.61
2018-03-31 $68k 4.3k 15.94
2017-12-31 $13k 801 16.23
2017-09-30 $66k 3.8k 17.36